Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Daxor Corp DXR

Healthcare Medical Devices
Daxor Corporation is a blood volume measurement technology company, which is focused on blood volume testing innovation. The Company has developed and marketed the Blood Volume Analyzer (BVA-100), the diagnostic blood test cleared by the food and drug administration (FDA) to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific... see more

Recent & Breaking News (NDAQ:DXR)

/ CORRECTION - Classic Textbook on Critical Care, the ICU book by Paul Marino, M.D., PhD., Recommends Direct Measurement of Blood Volume in Evaluating Critically Ill Patients

Marketwired January 7, 2014

Classic Textbook on Critical Care, the ICU book by Paul Marino, M.D., PhD., Recommends Direct Measurement of Blood Volume in Evaluating Critically Ill Patients

Marketwired January 7, 2014

Daxor Corporation Announces Payment of a Dividend

Marketwired November 15, 2013

Daxor Corporation Announces a Study on the Significant Diagnostic Benefits to Congestive Heart Failure Patients Utilizing the Daxor BVA-100 Blood Volume Analyzer

Marketwired October 25, 2013

Daxor Corporation Announces Results of Blood Volume Measurement Study at the Mayo Clinic Presented at the 17th Annual American Heart Failure Society Meeting in Orlando, Florida

Marketwired October 8, 2013

Daxor Corporation Announces Receipt of Blood Banking Contract From Prestigious Law Firm Stroock & Stroock & Lavan LLP

Marketwired August 7, 2013

Daxor Corporation Announces Publication of "Blood Volume Determination, A Nuclear Medicine Test in Evolution"

Marketwired July 11, 2013

Daxor Corporation Announces the Bi-Monthly Publication of a Medical Column by Its President, Dr. Joseph Feldschuh

Marketwired June 13, 2013

Daxor Corporation Announces Placement of BVA-100 Blood Volume Analyzer at Austin Nuclear Pharmacy, Inc.

Marketwired May 16, 2013

Heartbeat Clinic in Dallas Acquires Blood Volume Analyzer; Daxor Corporation Announces 250,000 Share Buyback

Marketwired March 21, 2013

Daxor Corporation Announces the Sale of a BVA-100 Blood Volume Analyzer to Banner Good Samaritan Medical Center of Phoenix, Arizona

Marketwired March 7, 2013

Daxor Corporation Announces Filing of Form N-CSR for December 31, 2012 and Volumex Kit Sales for 2012

Marketwired March 1, 2013

Reports of a Study Comparing Daxor's Direct Blood Volume Measurement With a Non-Invasive Hemoglobin Monitor in Critically Ill Surgical Patients

Marketwired February 14, 2013

A Study Evaluating Hyponatremia Utilizing the BVA-100 Is Presented at Annual 2013 Critical Care Congress

Marketwired January 31, 2013